Cargando…

Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis

OBJECTIVE: To investigate T cell and antibody immunity to Epstein–Barr virus (EBV) in multiple sclerosis (MS). METHODS: Immunoglobulin G (IgG) immunity to EBV nuclear antigen 1 (EBNA1) and viral capsid antigen was measured by enzyme linked immunosorbent assays, and T cell immunity was assessed using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pender, M P, Csurhes, P A, Lenarczyk, A, Pfluger, C M M, Burrows, S R
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2009
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663364/ https://www.ncbi.nlm.nih.gov/pubmed/19015225 http://dx.doi.org/10.1136/jnnp.2008.161018

Ejemplares similares

Decreased CD8(+ )T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes
por: Pender, Michael P, et al.
Publicado: (2011)

CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2011)

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2017)

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2017)

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

Deficiency of CD8(+) effector memory T cells is an early and persistent feature of multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
por: Pender, Michael P, et al.
Publicado: (2014)

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
por: Pender, Michael P., et al.
Publicado: (2020)

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
por: Hui-Yuen, Joyce, et al.
Publicado: (2011)

Epstein–Barr Virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Pediatric Population
por: Simbiri, Kenneth O., et al.
Publicado: (2015)

Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines
por: Chaiwongkot, Arkom, et al.
Publicado: (2020)

Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines
por: Chaiwongkot, Arkom, et al.
Publicado: (2021)

Calcium mobilization is responsible for Thapsigargin induced Epstein Barr virus lytic reactivation in in vitro immortalized lymphoblastoid cell lines
por: Hoji, Aki, et al.
Publicado: (2018)

The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
por: Pender, Michael P.
Publicado: (2011)

Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines
por: Kotaki, Ryutaro, et al.
Publicado: (2020)

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy
por: Ioannides, Zara A., et al.
Publicado: (2021)

Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines
por: Lee, Dong Hyeon, et al.
Publicado: (2006)

Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells
por: Markasz, Laszlo, et al.
Publicado: (2006)

Correction: Epstein-Barr Virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Pediatric Population
Publicado: (2015)

Host Genetic Variants and Gene Expression Patterns Associated with Epstein-Barr Virus Copy Number in Lymphoblastoid Cell Lines
por: Houldcroft, Charlotte J., et al.
Publicado: (2014)

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
por: Bar-Or, Amit, et al.
Publicado: (2020)

Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.
por: Miller, G.
Publicado: (1971)

Epstein-Barr virus induces adhesion molecule CD226 (DNAM-1) expression during primary B cell transformation into lymphoblastoid cell lines
por: Grossman, Lisa V, et al.
Publicado: (2012)

A simplified approach for derivation of induced pluripotent stem cells from Epstein-Barr virus immortalized B-lymphoblastoid cell lines
por: Walker, Stephen J., et al.
Publicado: (2021)

Efficient and reliable establishment of lymphoblastoid cell lines by Epstein-Barr virus transformation from a limited amount of peripheral blood
por: Omi, Natsue, et al.
Publicado: (2017)

COMPARISON OF THE YIELD OF INFECTIOUS VIRUS FROM CLONES OF HUMAN AND SIMIAN LYMPHOBLASTOID LINES TRANSFORMED BY EPSTEIN-BARR VIRUS
por: Miller, George, et al.
Publicado: (1973)

Epstein–Barr virus and multiple sclerosis
por: Soldan, Samantha S., et al.
Publicado: (2022)

Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines
por: Grossman, Lisa, et al.
Publicado: (2017)

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein–Barr Virus
por: Hatton, Olivia, et al.
Publicado: (2016)

Dendrosomal nanocurcumin prevents EBV-associated cell transformation by targeting the lytic cycle genes of the Epstein-Barr virus in the generation of lymphoblastoid cell line
por: Cheragh, Mahboobeh, et al.
Publicado: (2023)

Transition of Phenotypic Dimorphism with Regard to Spontaneous Sister Chromatid Exchange in Epstein‐Barr Virus‐transformed Bloom's Syndrome Lymphoblastoid Cell Lines
por: Tatsumi, Kouichi, et al.
Publicado: (1992)

The EBNA3 Family of Epstein-Barr Virus Nuclear Proteins Associates with the USP46/USP12 Deubiquitination Complexes to Regulate Lymphoblastoid Cell Line Growth
por: Ohashi, Makoto, et al.
Publicado: (2015)

Epstein-Barr Virus and Multiple Sclerosis
por: Houen, Gunnar, et al.
Publicado: (2020)

Induction of p16(INK4a) Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
por: Skalska, Lenka, et al.
Publicado: (2013)

Induction of epstein-barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines
por: Gargouri, Bochra, et al.
Publicado: (2011)

Epstein-Barr Virus- (EBV-) Immortalized Lymphoblastoid Cell Lines (LCLs) Express High Level of CD23 but Low CD27 to Support Their Growth
por: Yap, Hooi-Yeen, et al.
Publicado: (2019)

High-efficiency genomic editing in Epstein-Barr virus-transformed lymphoblastoid B cells using a single-stranded donor oligonucleotide strategy
por: Johnston, Andrew D., et al.
Publicado: (2019)

Correction: Induction of p16(INK4a) Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
por: Skalska, Lenka, et al.
Publicado: (2013)

A role for the Epstein–Barr virus in multiple sclerosis aetiology?
por: Hrastelj, J., et al.
Publicado: (2022)

Proteomics Analysis of Lymphoblastoid Cell Lines from Patients with Amyotrophic Lateral Sclerosis
por: Whitham, Danielle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_56vp0t95fcui405aua0iftv39s